Israel’s QLog took on the operational chaos of hospitals. Minovia took on a disease with fewer than 1,000 patients worldwide. Both succeeded through partnerships with leading European medical centers Developing a therapy for an ultra-rare disease presents a challenge long before the clinical trial begins…. | Read More in The Blogs
Alon Stopel | From the Single Cell to the Crash Cart



